全文获取类型
收费全文 | 16524篇 |
免费 | 1081篇 |
国内免费 | 326篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 247篇 |
妇产科学 | 1817篇 |
基础医学 | 1405篇 |
口腔科学 | 296篇 |
临床医学 | 1706篇 |
内科学 | 1063篇 |
皮肤病学 | 141篇 |
神经病学 | 350篇 |
特种医学 | 159篇 |
外科学 | 1043篇 |
综合类 | 1406篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 1380篇 |
眼科学 | 159篇 |
药学 | 5779篇 |
21篇 | |
中国医学 | 448篇 |
肿瘤学 | 454篇 |
出版年
2024年 | 31篇 |
2023年 | 335篇 |
2022年 | 386篇 |
2021年 | 708篇 |
2020年 | 584篇 |
2019年 | 652篇 |
2018年 | 765篇 |
2017年 | 716篇 |
2016年 | 726篇 |
2015年 | 729篇 |
2014年 | 1042篇 |
2013年 | 2562篇 |
2012年 | 794篇 |
2011年 | 977篇 |
2010年 | 652篇 |
2009年 | 846篇 |
2008年 | 789篇 |
2007年 | 660篇 |
2006年 | 594篇 |
2005年 | 504篇 |
2004年 | 466篇 |
2003年 | 344篇 |
2002年 | 275篇 |
2001年 | 217篇 |
2000年 | 206篇 |
1999年 | 165篇 |
1998年 | 148篇 |
1997年 | 137篇 |
1996年 | 121篇 |
1995年 | 114篇 |
1994年 | 93篇 |
1993年 | 101篇 |
1992年 | 85篇 |
1991年 | 59篇 |
1990年 | 63篇 |
1989年 | 54篇 |
1988年 | 30篇 |
1987年 | 21篇 |
1986年 | 37篇 |
1985年 | 33篇 |
1984年 | 19篇 |
1983年 | 29篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1975年 | 2篇 |
1974年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
Brand RM Hannah TL Mueller C Cetin Y Hamel FG 《Annals of biomedical engineering》2000,28(10):1210-1217
Medications introduced into the systematic circulation must be transported across biological barriers such as skin, gastrointestinal, or bronchial epithelia, which can alter their kinetic and metabolic profiles. It is, therefore, important to understand diffusion kinetics across barrier membranes when choosing a dosing regime that will elicit the greatest cellular response. An in vitro system that combines membrane transport studies with a downstream cell culture chamber has been developed. The system has been tested with skin and a small intestine model (Caco-2 cell monolayers) as barriers, the peroxovanadium compound [VO(O2)2 1, 10 phenanthroline] bpV(phen), as the test chemical, Hep-G2 (liver) as the test cells, and glucose consumption as the test assay. Peroxovanadium has insulin mimetic properties and has been previously demonstrated to effectively lower blood glucose levels in diabetic rats when administered transdermally. A dose of 10 mM bpV(phen) placed on the skin epidermis with a continuous iontophoretic current of 0.5 mA/cm2 for 4.5 h led to a net 22% increase in glucose consumption by Hep-G2 cells. The same dose of bpV(phen) passively diffusing across a Caco-2 cell monolayer led to an increase in glucose consumption by Hep-G2 cells of 23%. This system is highly versatile and can be used to study many other processes, involving a variety of biological membranes, cell types, chemicals and assays, making it a valuable research tool. © 2000 Biomedical Engineering Society.
PAC00: 8716Uv, 8715Vv 相似文献
102.
目的探讨阴道分娩和剖宫产对新生儿的风险。方法对6024例妊娠的分娩方式、剖宫产指征以及新生儿结局回顾性分析。结果剖宫产率为35.3%,其指征主要是头盆不称、社会因素、宫内窘迫、臀位等。分娩新生儿6016例,其中因各种疾患转儿科822例,占13.5%。主要转科原因为早产儿低体重、窒息、高胆红素血症和吸入综合症,各疾病发病率与分娩方式无关。结论剖宫产没有增加新生儿的风险,仍是解决难产的重要手段,但应严格控制手术指征。 相似文献
103.
目的以羧甲基壳聚糖为基质材料,制备apoptin基因缓释微球,探讨其对U937细胞凋亡的作用。方法采用复凝聚法制备apoptin/壳聚糖微球,分别用光镜观察微球形态、内切酶研究其稳定性、DNA电泳阻滞分析apoptin/壳聚糖最佳比例、PCR测定apoptin基因作为复制摸板能力、用MTT法检测其抗肿瘤活性。结果壳聚糖与apoptin基因可形成稳定的微球,其直径在200~300之间,成球性较好,apoptin/壳聚糖微球P/N最佳质量比为5.5:1。微球能够有效防止DNA酶的降解作用,apoptin/微球载体中的基因仍具有DNA复制摸板功能,并能有效地转染U937细胞,转染48h可诱导U937细胞发生凋亡,从而抑制瘤细胞生长。结论apoptin基因与羧甲基壳聚糖可形成稳定的缓释微球,并能有效地转染肿瘤细胞,诱导肿瘤细胞发生凋亡。 相似文献
104.
The transfer of genes of potential therapeutic benefit is presently being attempted in the clinic to treat a number of genetic and virally induced diseases. Many of these protocols use retroviral vectors derived from murine leukemia retroviruses as gene delivery systems. Although these viral delivery systems are well suited for this purpose, a number of their characteristics, some of which are discussed here, are still troublesome. Future retroviral vectors will incorporate nonretroviral features and will be tailored to desired needs for specific uses. These vectors will be safer, more efficient, and targeted in their delivery. Further, expression of the therapeutic genes carried will be limited to the specific target cell type. Some of the recent advances that have been made towards this goal are reviewed here. 相似文献
105.
心血管疾病基因治疗进展 总被引:1,自引:1,他引:1
载体是基因治疗的一个限速因素。本文主要介绍了近两年来基因运载体系,基因转移方式,新的基因治疗策略的进展以及它们在心血管中的应用。 相似文献
106.
透皮给药研究的新进展 总被引:6,自引:0,他引:6
透皮给药安全可控,是无创给药的新途径,有着广阔的市场前景。现有的透皮药物限于小分子和低浓度,角质层屏障使大多数药物难以通过或难以达到有效浓度和有效速率。透皮给药的关键在于促进药物渗透,使药物透皮吸收进毛细血管。促渗手段有:使用化学促渗剂;对药物进行化学修饰制成前体药物;使用物理方法;将药物载入载体。这些方法的原理大致分为三种:改变角质层结构;外力驱动药物;将药物进行修饰或包裹。简要地介绍了增强药物透皮的物理方法和载体方法研究的新进展。 相似文献
107.
Summary This study examined the rates of gastric emptying for water and 13 different carbohydrate-containing solutions in seven subjects, using conventional gastric intubation techniques. The rates of gastric emptying for water and a 10% glucose-polymer solution were also measured during 90 min of treadmill running at 75% of each subject's maximum oxygen consumption
. At rest, 15% glucose-polymer (P) and fructose (F) solutions emptied more rapidly from the stomach and provided a faster rate of carbohydrate delivery than did a 15% glucose (G) solution (p<0.05). The G solutions showed a constant energy delivery rate of 3.3 kcal · min–1; energy delivery from P and F solutions rose with increasing solution concentrations. The osmolality of the gastric aspirate predicted the rate of gastric emptying for all solutions (p<0.05) but overestimated rates of emptying for 10% and 15% P solutions and underestimated emptying rates for 10% and 15% F solutions. Exercise at 75%
decreased the rate of gastric emptying of water but not of 10% P solutions. Thus the different rates of gastric emptying for different carbohydrate-containing solutions were not entirely explained by differences in osmolality. Furthermore, exercise may have different effects on the gastric emptying rates of water and carbohydrate solutions. 相似文献
108.
Zilberman M 《Acta biomaterialia》2005,1(6):680-624
Bioresorbable polymer films containing dexamethasone (DM) were prepared using a solution processing technique. Investigation of the films focused on cumulative DM release as affected by film morphology (drug location/dispersion in the film) and degradation processes. Two film structures were studied: A-type, a polymer film with large drug crystals located on the film’s surface, and B-type, a polymer film with small drug particles and crystals distributed within the bulk. The effect of the polymer’s degree of crystallinity on the drug release profile was also studied. Prototypical applications of these films are biodegradable medical support devices which combine mechanical support with drug release. In most of our studied systems the drug release profile from the film is determined mainly by both drug location/dispersion in the film and the polymer’s weight loss rate. All release profiles from A-type films exhibited a burst effect of approximately 30%, accompanied by a second release phase at a constant rate, whereas the release profiles from B-type films were determined mainly by the degradation profile of the host polymer, and did not exhibit any burst effect. A high degree of crystallinity is important for the current application, since good mechanical properties are required. This contributes to slower drug release rates, mainly at relatively low weight losses, whereas at high weight losses, where a porous structure is created, the crystallinity almost does not affect the rate of drug release. The shape of the porous structure that develops with degradation also affects the drug release profile from the B-type films. 相似文献
109.
In Vitro and In Vivo Characterization of MEMS Microneedles 总被引:1,自引:0,他引:1
Transdermal drug delivery TDD systems have many advantages but are conventionally limited by the low permeability of skin. The idea of using microneedles to painlessly penetrate the topmost impermeable stratum corneum has previously been put forward. In this paper, the fabrication of solid and hollow silicon microneedles with straight side-walls and with the following dimensions: 20–100 m in diameter and 100–150 m in length is described. In vitro tests demonstrate that with prior solid microneedle application, transdermal drug transport is significantly increased by 10–20 times, with the degree of enhancement being related to needle diameter. In vivo tests in diabetic animals, however, were unable to demonstrate any delivery of insulin through the hollow microneedles. It is proposed that two factors, microneedle length and tip sharpness, have to be improved for systemic drug delivery to be seen in vivo. 相似文献
110.
目的 研究球形实体肿瘤中生理参数对药物输运的影响,以及探讨有较好效果的药物注射方式。方法 设肿瘤中毛细血管网成球对称分布,肿瘤中的毛细血管表面积和肿瘤体积之比为半径的函数。肿瘤间质为多孔介质,化学药物透过毛细血管壁进入肿瘤间质,在肿瘤间质中输运满足扩散方程。肿瘤外正常组织富含血管和淋巴,药物能被淋巴管吸收,药物输运采用改进的药代动力学模型。用肿瘤中各部位药物浓度维持在最小药物浓度MEC水平以上的时间曲线面积(AUC)来衡量药物的效果。结果 增大肿瘤间质中毛细血管对药物的通透性P,提高药物在肿瘤间质的扩散系数D,AUC的值均增大。在给出的六种给药方式中,分时段连续滴注和等时间间隔一次性注射的给药方式,它们的AUC值最大。结论 增大肿瘤间质中毛细血管对药物的通透性,提高药物在肿瘤间质的扩散系数,以及采用分时段连续滴注和等时间间隔一次性注射的给药方式,有利于肿瘤的治疗。 相似文献